The American Journal of Digestive Diseases

, Volume 8, Issue 10, pp 789–797 | Cite as

Clinical interpretation of serum β-glucuronidase activity

  • Alexander M. Rutenburg
  • Esteban P. Pineda
  • Benjamin M. Banks
  • Julius A. Goldbarg
Article

Summary

1. Serum β-glucuronidase activity was assayed in 1134 patients with hepatobiliary or pancreatic diseases.

2. This test proved to be the most sensitive for the detection of mild to moderate cirrhosis in theanicteric patient. Conversely, the presence of this disease is unlikely if the serum β-glucuronidase is normal. Consequently, the β-glucuronidase assay is a valuable screening test for this disease.

3. Increased serum β-glucuronidase activity was as sensitive as index of hepatic dysfunction in patients with acute hepatitis or drug-induced jaundice as the serum glutamic oxalacetic transaminase test and was more sensitive than the other hepatic tests commonly employed in the confirmation of these diseases. Furthermore, serial assays were of value in assessing the clinical course of the disease.

4. The serum β-glucuronidase test is relatively nonspecific, since elevations were observed in a variety of diseases affecting the liver as well as during pregnancy and after the administration of estrogens. The considerable overlap of values in obstructive and primary hepatic jaundice renders the β-glucuronidase test of limited value in the differential diagnoisis of jaundice.

5. The pathophysiologic alterations underlying variations of serum β-glucuronidase activity in hepatobiliary disease are discussed.

Keywords

Public Health Hepatitis Estrogen Screening Test Acute Hepatitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rutenburg, S. H., andSeligman, A. M. Colorimetric estimation of β-D-glucuronidase activity with 8-benzoylamino-2-naphthyl β-D-glucuronide.J. Biol. Chem. 203: 731, 1953.PubMedGoogle Scholar
  2. 2.
    Fishman, W. H., Green, S., Homburger, F., Kasdon, S. C., Nieburgs, H. E., McInnis,G., andPund, E. R. VII. Premenopausal vaginal fluid β-glucuronidase values in relation to in situ cancer of the cervix.Cancer 7: 729, 1954.PubMedGoogle Scholar
  3. 3.
    Fishman, W. H., Anlyan, A. J., andGordon, E. β-Glucuronidase activity in human tissues; some correlations with processes of malignant growth and with the physiology of reproduction.Cancer Res. 7:808, 1947.Google Scholar
  4. 4.
    Pineda, E. P., Goldbarg, J. A., Banks, B. M., andRutenburg, A. M. The significance of serum β-glucuronidase activity in patients with liver disease.Gastroenterology 36:202, 1959.PubMedGoogle Scholar
  5. 5.
    Friedenwald, J. S., andBecker, B. The histochemical localization of glucuronidase.J. Cell & Comp. Physiol. 31:303, 1948.Google Scholar
  6. 6.
    Campbell, J. G. The intracellular localization of β-glucuronidase.Brit. J. Exper. Path. 30:548, 1949.Google Scholar
  7. 7.
    Unpublished observations.Google Scholar
  8. 8.
    Fishman, W. H., Odell, L. D., Gill, J. E., andChristensen, R. A. The influence of stilbestrol on serum β-glucuronidase in women following parturition.Am. J. Obst. & Gnec. 59:414, 1950.Google Scholar
  9. 9.
    Fishman, W. H., Kasdon, S. C., Bonner, C. D., Fishman, L. W., andHomburger, F. β-Glucuronidase studies in women. V. The menstrual cycle and serum β-glucuronidase activity in estrogen treated postmenopausal subjects.J. Clin. Endocrinol. 11:1425, 1951.Google Scholar
  10. 10.
    Cohen, S. L., andHuseby, R. A. The effect of estrogen on serum glucuronidase activity of patients with breast cancer.Cancer Res. 11:52, 1951.PubMedGoogle Scholar
  11. 11.
    Selicman, A. M., Tsou, K-C., Rutenberg, S. H., andCohen, R. B. Histochemical demonstration of β-glucuronidase with a synthetic substrate.J. Histochem. 2:209, 1954.Google Scholar
  12. 12.
    Goldbarg, J. A., Pineda, E. P., Banks, B. M., andRutenberg, A. M. A method for the colorimetric determination of β-glucuronidase in urine, serum, and tissue; Assay of enzymatic activity in health and disease.Gastroenterology 36:193, 1959.PubMedGoogle Scholar
  13. 13.
    Pineda, E. P., Goldbarg, J. A., andRutenburg, A. M. Serum enzymes in the diagnosis of pancreatic and hepatic disease in anicteric patients.S. Forum 10:249, 1960.Google Scholar
  14. 14.
    Pineda, E. P., Goldbarg, J. A., Levitan, R., andRutenburg, A. M. Leucine aminopeptidase and β-glucuronidase activity in cancerous and noncancerous effusions.Am. J. Digest. Dis. 7:797, 1962.PubMedGoogle Scholar
  15. 15.
    West, M., andZimmerman, H. J. Serum enzymes in hepatic disease.M. Clin. North America 43:1, 1959.Google Scholar

Copyright information

© Hoeber Medical Division of Harper & Row, Publishers, Incorporated 1963

Authors and Affiliations

  • Alexander M. Rutenburg
    • 1
    • 2
    • 3
  • Esteban P. Pineda
    • 1
    • 2
    • 3
  • Benjamin M. Banks
    • 1
    • 2
    • 3
  • Julius A. Goldbarg
    • 1
    • 2
    • 3
  1. 1.From the Yamins Laboratory for Surgical ResearchBeth Israel HospitalUSA
  2. 2.the Departments of SurgeryBeth Israel HospitalUSA
  3. 3.Harvard Medical SchoolBoston

Personalised recommendations